-       Report 
   - November 2025
    -  482 Pages 
    Global
   
   From       €5249EUR$5,850USD£4,607GBP 
                  -       Clinical Trials 
   - April 2025
    -  60 Pages 
    Global
   
   From       €1077EUR$1,200USD£945GBP 
      €1346EUR$1,500USD£1,181GBP 
                  -       Clinical Trials 
   - April 2025
    -  60 Pages 
    Global
   
   From       €897EUR$1,000USD£788GBP 
      €1122EUR$1,250USD£984GBP 
                  -       Report 
   - December 2024
    -  84 Pages 
    Global
   
   From       €2836EUR$3,160USD£2,489GBP 
      €3544EUR$3,950USD£3,111GBP 
                  -       Report 
   - August 2025
    -  193 Pages 
    Global
   
   From       €3181EUR$3,545USD£2,792GBP 
      €3535EUR$3,939USD£3,102GBP 
                 -       Report 
   - July 2025
     Global
   
   From       €4397EUR$4,900USD£3,859GBP 
                  -       Report 
   - October 2025
    -  148 Pages 
    Global
   
   From       €2287EUR$2,549USD£2,008GBP 
      €2691EUR$2,999USD£2,362GBP 
                -       Report 
   - February 2025
    -  183 Pages 
    Global
   
   From       €4038EUR$4,500USD£3,544GBP 
                -       Report 
   - June 2025
    -  150 Pages 
    Global
   
   From       €2422EUR$2,699USD£2,126GBP 
                -       Report 
   - June 2025
    -  200 Pages 
    Global
   
   From       €2503EUR$2,789USD£2,196GBP 
                -       Drug Pipelines 
   - June 2025
    -  200 Pages 
    Global
   
   From       €2503EUR$2,789USD£2,196GBP 
                -       Report 
   - September 2025
    -  117 Pages 
    Global
   
   From       €3500EUR$4,178USD£3,179GBP 
                -       Report 
   - March 2025
    -  210 Pages 
    Global
   
   From       €4482EUR$4,995USD£3,934GBP 
                  -       Report 
   - August 2025
    -  150 Pages 
    Global
   
   From       €3013EUR$3,358USD£2,644GBP 
      €3544EUR$3,950USD£3,111GBP 
                -       Report 
   - September 2025
    -  210 Pages 
    Global
   
   From       €4482EUR$4,995USD£3,934GBP 
                  -       Report 
   - February 2025
    -  130 Pages 
    Global
   
   From       €3699EUR$4,123USD£3,247GBP 
      €4352EUR$4,850USD£3,820GBP 
                  -       Report 
   - August 2025
    -  122 Pages 
    North America
   
   From       €2287EUR$2,549USD£2,008GBP 
      €2691EUR$2,999USD£2,362GBP 
                -       Report 
   - November 2024
    -  90 Pages 
    North America
   
   From       €3096EUR$3,450USD£2,717GBP 
                -       Report 
   - November 2024
    -  84 Pages 
    Middle East, Africa
   
   From       €3096EUR$3,450USD£2,717GBP 
                -       Report 
   - November 2024
    -  90 Pages 
    Europe
   
   From       €3096EUR$3,450USD£2,717GBP 
             
         Oxycodone is an opioid analgesic medication used to treat moderate to severe pain. It is a semi-synthetic opioid derived from thebaine, an alkaloid found in the opium poppy. Oxycodone is available in both immediate-release and extended-release formulations, and is commonly prescribed in combination with other analgesics such as acetaminophen or ibuprofen. Oxycodone is one of the most widely prescribed analgesics in the United States, and is used to treat a variety of conditions including chronic    pain, post-operative pain, and cancer-related pain.
Oxycodone is a key player in the analgesic market, and is often used in combination with other analgesics to provide more effective pain relief. It is also used in combination with non-opioid analgesics such as non-steroidal anti-inflammatory drugs (NSAIDs) to reduce the risk of opioid-induced side effects. Oxycodone is available in both generic and brand-name formulations, and is available in a variety of dosage forms including tablets, capsules, and oral solutions.
Some companies in the Oxycodone market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Mylan Pharmaceuticals. Show Less   Read more